Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 janv. 2023 08h00 HE | Source: Volta Medical

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced

New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving...
31 août 2022 08h00 HE | Source: Volta Medical

Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication

Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent...
27 avr. 2022 08h00 HE | Source: Volta Medical

Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022

- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress - MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) -- Volta...
21 déc. 2021 08h00 HE | Source: Volta Medical

First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis

Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial...